PharVision Advisers’s Wabash National WNC Stock Holding History

PharVision Advisers’s Portfolio WNC Stock Details WNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22,924	Closed	-$198K	–	654
2025 Q4	$198K	Buy	+22,924	New	+$200K	0.1%	563

Other funds holding WNC

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PharVision Advisers's WNC Position: Q1 2026 in Review

PharVision Advisers sold out of Wabash National (WNC) in Q1 2026, closing a stake of 22,924 shares — an estimated $198K sold.

PharVision Advisers first reported a position in WNC in Q4 2025 and held it in 1 quarter. The position peaked at $198K in Q4 2025. 171 funds tracked by Wall St. Rank hold WNC as of Q1 2026.

PharVision Advisers reported no remaining Wabash National position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 22,924 Wabash National shares in Q1 2026, an estimated $198K.
PharVision Advisers first reported a position in Wabash National in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Wabash National position peaked at $198K in Q4 2025.
171 funds tracked by Wall St. Rank held Wabash National as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.